Valuation : LivaNova PLC

Market Cap 4.51B 3.88B 3.65B 3.33B 6.23B 427B 6.25B 43.28B 16.73B 219B 16.95B 16.58B 696B P/E 2026 *
20.5x
P/E 2027 * 24.7x
Enterprise Value 4.59B 3.95B 3.71B 3.39B 6.34B 434B 6.36B 44B 17.01B 222B 17.23B 16.85B 708B EV / Sales 2026 *
3.01x
EV / Sales 2027 * 2.72x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day+0.89%
1 week+2.64%
Current month+2.64%
1 month+7.48%
3 months+13.21%
6 months+28.32%
Current year+33.14%
1 week 80.16
Extreme 80.16
83.52
1 month 75.04
Extreme 75.04
83.52
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 A Sell

Director

-1,650 0.0030%
8/11/26 A Exercice

Executive/Senior Manager

38,076 0.0693%
6/10/26 A Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+2.64%+41.31%+51.51% 4.51B
-0.42%-1.84%-18.51%+7.61% 187B
+1.15%+3.88%+1.37%+17.82% 120B
-1.86%+2.27%+13.15%+85.74% 63.15B
-2.28%-5.12%+13.78%+47.04% 51.75B
-1.54%-1.79%-3.98%-30.82% 50.32B
-2.02%-3.47%+9.18%-16.21% 33.17B
0.00%+4.45% - - 32.1B
-0.81%-0.33%+35.59%-15.82% 23.93B
-2.15%-8.67%-12.55%+8.93% 22.99B
Average -0.89%-0.23%+8.82%+17.31% 58.98B
Weighted average by Cap. -0.64%-0.62%-1.63%+16.84%

Financials

2026 *2027 *
Net sales 1.52B 1.31B 1.23B 1.12B 2.1B 144B 2.11B 14.6B 5.64B 73.71B 5.72B 5.59B 235B 1.63B 1.4B 1.32B 1.2B 2.25B 154B 2.26B 15.63B 6.04B 78.95B 6.12B 5.99B 251B
Net income 226M 195M 183M 167M 312M 21.4B 313M 2.17B 839M 10.96B 850M 831M 34.9B 187M 161M 151M 138M 258M 17.68B 259M 1.79B 693M 9.05B 702M 687M 28.84B
Net Debt 75M 64.5M 60.66M 55.38M 104M 7.09B 104M 719M 278M 3.63B 282M 275M 11.57B -85M -73.1M -68.75M -62.76M -117M -8.04B -118M -815M -315M -4.12B -319M -312M -13.11B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
04/09/26 $81.92 +0.89% 334,168
03/09/26 $81.20 -1.46% 694,084
02/09/26 $82.40 +2.79% 769,662
01/09/26 $80.16 +0.44% 585,411
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
81.92USD
Average target price
89.10USD
Spread / Average Target
+8.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!